Glucose-dependent insulinotropic peptide analogs
US9023986B2 · kind B2 · utility
0Cited by
4References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2011 |
| Grant date | May 5, 2015 |
| Priority date | — |
| Expiry date | Feb 25, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds which are analogs of glucose-dependent insulinotropic polypeptide (GIP) and pharmaceutically acceptable salts of such compounds. These compounds have activity as agonists of GIP receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.